Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pravin Dugel Insider Profile
4 Followers
Pravin Dugel, Director at Aadi Bioscience, holds 3.54M shares in Ocular Therapeutix (Ticker: OCUL), holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds 12.57K shares in Aadi Bioscience (Ticker: AADI).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+4.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pravin Dugel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pravin Dugel
Pravin Dugel's Trading History
Aadi Bioscience
Jul 02, 2021
Director
Uninformative Buy
9.62K
$35.06K
IVERIC bio
Jul 13, 2023
―
Uninformative Sell
―
$0.00
Ocular Therapeutix
Feb 13, 2025
Executive Chairman, President and CEO, Director
Uninformative Buy
―
$24.79M
List of latest transactions for each holding click on a transaction to see Pravin Dugel's performance on stock
You May Also Like
Pravin Dugel insider profile FAQ
What is the percentage of profitable transactions made by Pravin Dugel?
The percentage of profitable transactions made by Pravin Dugel is 67%.
What is the average return per transaction made by Pravin Dugel?
The average return per transaction made by Pravin Dugel is 4.40%.
What stocks does Pravin Dugel hold?
Pravin Dugel holds: AADI, ISEE, OCUL stocks.
What was Pravin Dugel’s latest transaction?
Pravin Dugel latest transaction was an Uninformative Buy of ―.
What was Pravin Dugel's most profitable transaction?
Pravin Dugel’s most profitable transaction was an Informative Sell of OCUL stock on November 27, 2024. The return on the trade was 24.70%.
What is Pravin Dugel's role in Aadi Bioscience?
Pravin Dugel's role in Aadi Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.